Diagnostic and Interventional Cardiology

VIDEO: Overview of Multisystem Inflammatory Syndrome in Children (MIS-C) in COVID-19 Exposed Children

Deepika Thacker, M.D., a pediatric cardiologist with Nemours Children’s Health System, Wilmington, Del., helped discover ...

September 29, 2020

News | Coronavirus (COVID-19)

ECMO Support Found Effective in Sickest of COVID-19 Patients

September 29, 2020 – Extracorporeal membrane oxygenation (ECMO) support saved lives in past epidemics of lung-damaging ...

September 29, 2020

News | EP Mapping and Imaging Systems

FDA Clears Second-Generation AcQMap 3D EP Imaging and Mapping Catheter

September 29, 2020 — The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the second-generation of ...

September 29, 2020

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

The artificial intelligence-driven Caption Guidance software guides point of care ultrasound (POCUS) users to get optimal cardiac ultrasound images. The AI software is an example of a FDA-cleared software that is helping improve imaging, even when used by less experienced users.

Feature | Artificial Intelligence | Joe Fornadel, J.D., and Wes Moran, J.D.

Recent Developments in Artificial Intelligence and Accompanying Liability Risks

The number of Federal Drug Administration (FDA)-approved AI-based algorithms is significant and has grown at a steady ...

September 29, 2020

Boston Scientific launched the Acurate neo2 transcatheter aortic valve replacement (TAVR) system in Europe. This next-generation transcatheter aortic valve implantation (TAVI) technology is a new platform designed with a number of features to improve upon the clinical performance of the original Acurate neo platform. Compared to the previous generation device, the Acurate neo2 valve system also has an expanded indication for patients with aortic stenosis. #TAVR #TAVI

News | Heart Valve Technology

Boston Scientific Launches Acurate neo2 Transcatheter Aortic Valve System in Europe

September 29, 2020 — Boston Scientific launched the Acurate neo2 transcatheter aortic valve replacement (TAVR) system in ...

September 29, 2020

Videos | Artificial Intelligence

VIDEO: Use of Artificial Intelligence in Nuclear Imaging

Ernest Garcia, Ph.D., MASNC, FAHA, endowed professor in cardiac imaging, director of nuclear cardiology R&D laboratory ...

September 25, 2020

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

hort-term hydroxychloroquine treatment is not associated with lethal heart rhythms in patients with COVID-19 (SARS-CoV-2) who are risk assessed prior to receiving the drug. That is the finding of research published today in EP Europace, a journal of the European Society of Cardiology (ESC). #COVID19 #SARSCoV2 #hydroxychloroquine

News | Coronavirus (COVID-19)

Short-term Hydroxychloroquine Use in COVID-19 Patients Does Not Cause Lethal Arrhythmias if Screened

September 25, 2020 — Short-term hydroxychloroquine treatment is not associated with lethal heart rhythms in patients ...

September 25, 2020

The VitalPatch RTM biosensor is being used in the TELESTAR-TAVR clinical study (Deployment of Telemedicine for Symptom Tracking And Decrease Readmission Rate in TAVR Patients). It will evaluate patients who undergo a transcatheter aortic valve replacement (TAVR) and monitor them following the procedure utilizing the latest technology from VitalConnect, VistaSolution LIVE.

News | Wearables

VitalConnect Announces Initiation of TELESTAR-TAVR Clinical Study

September 25, 2020 — Remote and in-hospital wearable biosensor technology company VitalConnect Inc. has started the ...

September 25, 2020

Philips introduced the QuickClear Mechanical Thrombectomy System. It is a simple thrombectomy solution provides physicians with an all-in-one, single-use aspiration catheter and pump system.

News | Thrombectomy Devices

Philips Introduces QuickClear Mechanical Thrombectomy System for Blood Clot Removal

September 25, 2020 — Philips Healthcare launched its QuickClear mechanical thrombectomy system. The compact, single-use ...

September 25, 2020

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

EchoGo Pro automates cardiac ultrasound measurements for heart functions, but also empower physicians to predict the occurrence of coronary artery disease (CAD).

News | Cardiovascular Ultrasound

Ultromics Earns Frost & Sullivan Innovation Award for Pioneering AI-based Cardiac Echo Software

September 25, 2020 — Based on its recent analysis of the global artificial intelligence (AI)-based echocardiography ...

September 25, 2020

An example of a CT coronary artery calcium scoring exam showing how each vessel segment is scored to assess a patient's risk for a future heart attack. Example is from Philips Healthcare.

News | Cardiac Imaging

Study Finds Removing Cost from Calcium Score Testing Increased Utilization

September 25, 2020 — A study out of University Hospitals (UH) found that removing the cost barrier for coronary artery ...

September 25, 2020

SARS-CoV-2 infection of cells shown in green, left. This is inhibited by a modified form of cholesterol called 25-hydroxycholesterol (25HC), as seen in the cells in the right image. 25HC activates an enzyme called ACAT, found inside cells in the endoplasmic reticulum. ACAT then depletes accessible cholesterol on the cell’s membrane. It is a normally occurring process that gets kicked into high gear during some viral infections. Image from UC San Diego Health Sciences.

News | Coronavirus (COVID-19)

Statins May Reduce COVID-19 Severity

September 24, 2020 — Analyzing anonymized patient medical records, University of California (UC) San Diego Health ...

September 24, 2020

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

Fitbit Sense is the company’s first device compatible with an ECG app that enables users to take a spot check reading of their heart that can be analyzed for the heart rhythm irregularity atrial fibrillation (AFib).

News | Wearables

Fitbit ECG App to Identify Atrial Fibrillation Receives Regulatory Clearance in U.S. and Europe

September 24, 2020 — Fitbit received 510(k) clearance from the U.S. Food and Drug Administration (FDA), as well as ...

September 24, 2020

The Optimizer Smart System is a pacemaker-like device that improves heart function and reduces debilitating symptoms associated with the disease, including fatigue and shortness of breath.

News | Heart Failure

Allegheny General Hospital Cardiologists First in the Region to Use Novel Implantable Device to Treat Heart Failure

September 23, 2020 – A team of cardiologists at Allegheny General Hospital (AGH), part of Allegheny Health Network (AHN) ...

September 23, 2020

The Farapulse pulsed field ablation (PFA) system, also referred to as electroporation, ablates heart tissue using the creation of an electric field instead of using thermal energy sources such as radiofrequency ablation or cryoablation.

News | EP Lab

Boston Scientific Invests in Pulsed Field Ablation Technology To Improve Atrial Fibrillation Therapy

September 23, 2020 — Boston Scientific Corp. signed an investment agreement with an exclusive option to acquire ...

September 23, 2020